Phase I/IIa clinical trial in Duchenne muscular dystrophy using systematically delivered morpholino antisense oligomer to skip exon 53.

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/1231/10/15

Funding

  • European Union: £156,480.00